Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Vynleads, Inc.

Ticker
VYND
Sector
Industry
Report date
April 2, 2026
Valye AI Score

86

Very high visibility
Recent developments
Recent developments summary

Recent news highlights Vynleads' launch of the Done With Diabetes app featuring AI-powered lifestyle support, unveiling of the broader Done With Lifestyle Blueprint technology platform, and graduation to the OTCQB Venture Market.

Recent developments:
  • Vynleads launched the Done With Diabetes™ app, providing AI-powered daily lifestyle support focused on blood sugar and metabolic health [N1].
  • The company unveiled the "Done With" Lifestyle Blueprint™ technology platform and prepared for the app launch, signaling a strategic shift toward a scalable, AI-enabled wellness platform [N2].
  • Vynleads graduated to the OTCQB Venture Market, marking a milestone in its public market presence [N3].
  • The company highlighted its DWD Protocol and targeted nutraceuticals as supportive for type-2 diabetics amidst health uncertainties [N4].
Overview

Vynleads, Inc. operates as a wellness technology company targeting metabolic health and chronic lifestyle-influenced conditions. Its primary product is the Done With Diabetes app, an eight-week structured program designed to support adults with type 2 diabetes and related conditions through lifestyle education, habit formation, and AI-enabled coaching. The platform integrates a proprietary personalization engine and an emerging agentic AI architecture to deliver daily missions, meal guidance, community features, and ongoing maintenance support. The company is shifting from one-time digital wellness products to a recurring subscription model priced at $29 per month, aiming to scale direct-to-consumer subscriptions and enterprise partnerships with employers, health plans, and payers. The platform is cloud-based and relies on third-party technology providers, with a small internal team. Vynleads faces competition from established digital health and wellness vendors and operates under various regulatory frameworks related to consumer protection, privacy, and AI use.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Vynleads, Inc. is a wellness technology company focused on metabolic health, delivering its flagship Done With Diabetes app-based program with AI-enabled coaching and a subscription revenue model. The company is transitioning from discrete wellness products to a recurring digital platform emphasizing personalization, engagement, and scalability through AI. As of December 31, 2025, the company reported no revenue, a net loss of $255,066, and limited liquidity with a current ratio of 0.13. The business faces competitive, regulatory, operational, and execution risks inherent in early-stage digital health ventures.

Scenarios for VYND

Bull case model:

The company leverages AI and agentic workflows to provide personalized, scalable lifestyle wellness support, potentially differentiating it from competitors reliant on static content or labor-intensive coaching. Its recurring subscription model aligns incentives with long-term user engagement and retention. The platform's extensibility to additional chronic conditions beyond diabetes could broaden its market opportunity. Digital-native marketing and enterprise partnership strategies may enable diversified revenue streams and growth.

Bear case model:

Vynleads faces significant execution risks transitioning from discrete wellness products to a subscription platform, including challenges in user acquisition, retention, and engagement. The company's limited financial resources and small internal team may constrain product development and scaling. Competition from larger, established digital health vendors with greater resources may limit market penetration. Regulatory scrutiny, cybersecurity risks, and reliance on third-party providers add operational vulnerabilities. The absence of current revenue and negative net income highlight early-stage financial challenges.

Moat:

Vynleads' moat is centered on its proprietary AI-enabled platform architecture, including the Lifestyle Blueprint personalization engine and Dr. Smith AI Coach, which aim to deliver personalized, scalable wellness support. The emerging agentic AI workflows that coordinate specialized AI agents for conversational coaching and community engagement represent a technological differentiation. The company's brand portfolio and structured content libraries support its positioning in metabolic health. However, the company operates in a highly competitive market with larger, better-resourced competitors, and its limited scale and resources constrain its competitive advantage.

Risks overview
Risks summary
The primary risk is the company's ability to successfully transition and scale its app-based subscription platform while maintaining user engagement and navigating competitive, regulatory, and operational challenges.
Risks details:

• Transition to Subscription Model: The shift to an app-based subscription and platform model may not succeed due to challenges in acquiring and retaining users, maintaining engagement, and realizing operational leverage from AI workflows [S1].
• User Engagement and Retention: Sustained user engagement and perceived relevance are critical; failure to maintain these could lead to cancellations, inactivity, and negative brand impact [S1].
• Competitive Market: The company operates in a highly competitive and rapidly evolving market with competitors having substantially greater financial and organizational resources [S1].
• Regulatory and Compliance Risks: Operations are subject to various laws and regulations including consumer protection, privacy, AI governance, and subscription practices, which may impose constraints or require costly adaptations [S1].
• Cybersecurity and Third-Party Dependence: Reliance on cloud infrastructure and third-party vendors exposes the company to risks from security incidents, service disruptions, and vendor policy changes [S1].
• Limited Internal Resources: With only one employee and reliance on external consultants and partners, the company may face challenges in operational execution and scaling [S1].

FINAL FORECAST FOR VYND

Final take one line
Vynleads is an early-stage wellness technology company advancing an AI-enabled subscription platform for metabolic health with moderate visibility into its evolving business model and execution risks.
Final take 12 to 24 month view

Business trends: Transitioning from discrete wellness products to a recurring AI-enabled subscription platform focused on metabolic health, with plans to expand into additional chronic conditions.
Execution milestones: Launch of the Done With Diabetes app, unveiling of the broader Lifestyle Blueprint platform, and pursuit of enterprise partnerships.
Key risks: User acquisition and retention challenges, competitive pressures from larger vendors, regulatory compliance, cybersecurity vulnerabilities, and limited internal resources.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

86
LLM visibility overview
LLM Visibility known facts
  • Vynleads, Inc. is a Delaware corporation formed in July 2015 focused on wellness technology for metabolic health and chronic lifestyle-influenced conditions [S1].
  • The flagship product is Done With Diabetes, an eight-week structured, app-based lifestyle-first wellness support program targeting adults with type 2 diabetes, prediabetes, and related metabolic health goals [S1].
  • The Done With Diabetes program is delivered via a digital platform featuring a proprietary Lifestyle Blueprint personalization engine, Dr. Smith AI Coach, and an emerging agentic AI support architecture [S1].
  • The program is designed as a 56-day journey with four phases (Foundation, Meal Plan, Lifestyle, Control) and includes daily missions, educational content, meal guidance, recipe recommendations, check-ins, progress dashboards, coaching prompts, and community features [S1].
  • The platform emphasizes recurring digital engagement, AI-enabled coaching, community-driven support, and scalable architecture with specialized AI agents coordinating user support [S1].
  • After the initial program, users enter a Lifetime Wellness Mode for maintenance and relapse prevention with ongoing recommendations and challenges [S1].
  • The company positions its offerings as educational and wellness support, not medical diagnosis or treatment, advising users to consult healthcare professionals [S1].
  • Revenue model centers on a subscription priced at $29 per month following a seven-day free trial, emphasizing recurring digital revenue and user retention [S1].
  • Vynleads also plans to pursue enterprise distribution to self-insured employers, health plans, payers, provider groups, and pharmacy benefit managers, with potential recurring revenue arrangements [S1].
  • The company historically generated revenue from discrete digital wellness products, newsletters, and nutritional supplements but is now focused on scaling the app-based subscription platform and AI capabilities [S1].
  • Marketing is digitally native, combining branded website traffic, educational content, social media, referrals, community engagement, and performance marketing to attract users [S1].
  • Enterprise sales involve longer cycles and require product enhancements, administrative tooling, and reporting capabilities beyond the consumer experience [S1].
  • The platform architecture is cloud-based, managing user accounts, onboarding, program enrollment, daily tasks, AI chat sessions, subscriptions, and administrative reporting [S1].
  • AI features include Dr. Smith AI Coach and agentic AI workflows that coordinate specialized agents for conversational coaching, knowledge retrieval, pattern recognition, and community support [S1].
  • The company holds trademarks and proprietary rights including Vynleads, Done With Diabetes, Lifestyle Blueprint, and Dr. Smith AI Coach [S1].
  • Operations are subject to various laws and regulations including consumer protection, privacy, data security, advertising, subscription practices, and AI governance [S1].
  • As of March 24, 2026, the company had one employee (the CEO) and relies heavily on third-party service providers and consultants [S1].
  • Financial snapshot as of December 31, 2025: cash and equivalents of $44,628; current assets $53,709; current liabilities $406,140; revenue $0; net loss $255,066; basic and diluted EPS of -$0.01; current ratio 0.13; cash ratio 0.11 [S1].
  • The company faces competitive pressures from digital wellness apps, diabetes education services, coaching programs, and enterprise wellness vendors with greater resources [S1].
  • Key risks include the transition to an app-based subscription model, user engagement and retention challenges, competition, regulatory scrutiny, cybersecurity risks, reliance on third-party vendors, and dependence on limited internal personnel [S1].
  • Recent developments include launching the Done With Diabetes app with AI-powered daily lifestyle support, unveiling the broader Done With Lifestyle Blueprint technology platform, and graduating to the OTCQB Venture Market [N1][N2][N3].
  • The company emphasizes AI-enabled and agentic support workflows to personalize member experiences and improve scalability without proportional increases in human support [S1].
Sources
Sources - Context summary

Generated 2026-04-03

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-31 | 10-K
  • S2 | 2025-11-12 | 10-Q
Sources - News headlines
  • N1 | 2026-02-11 | www.nasdaq.com | Vynleads (OTCQB: VYND) Launches Done With Diabetes™ App, Bringing AI-Powered Daily Lifestyle Support to Blood Sugar and Metabolic Health | https://www.nasdaq.com/press-release/vynleads-otcqb-vynd-launches-done-diabetestm-app-bringing-ai-powered-daily-lifestyle
  • N2 | 2026-01-28 | www.nasdaq.com | Vynleads Unveils "Done With" Lifestyle Blueprint™ Technology Platform; Readies App Launch | https://www.nasdaq.com/press-release/vynleads-unveils-done-lifestyle-blueprinttm-technology-platform-readies-app-launch
  • N3 | 2020-07-21 | www.nasdaq.com | Vynleads Graduates to OTCQB Venture Market | https://www.nasdaq.com/press-release/vynleads-graduates-to-otcqb-venture-market-2020-07-21
  • N4 | 2020-07-06 | www.nasdaq.com | Vynleads’ DWD Protocol & Targeted Nutraceuticals Can Support Type-2 Diabetics Amidst Health Uncertainty | https://www.nasdaq.com/press-release/vynleads-dwd-protocol-targeted-nutraceuticals-can-support-type-2-diabetics-amidst
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine